Braunstein Scott
- SEC CIK
- 0001643875
No open-market purchases or sales filed in the past year.
Current role at each company
- ATAI AtaiBeckley Inc.Directoras of Sep 11, 2026
- RAPT RAPT Therapeutics, Inc.Directoras of Mar 5, 2026
- CRBU Caribou Biosciences, Inc.Directoras of Feb 20, 2026
- MRNS Marinus Pharmaceuticals, Inc.CHAIRMAN AND CEOas of Feb 11, 2025
- TRVN Trevena IncDirectoras of Jun 17, 2024
Show 1 more company
- CNST Constellation Pharmaceuticals IncDirectoras of Jul 19, 2021
Open-market trades in the past year
Open-market purchases (P) and sales (S) filed in the last 365 days, not counting derivative securities or duplicate filings. Values leave out price outliers.
- Bought
- –
- 0 filings
- Sold
- –
- 0 filings
- Net
- –
- Bought minus sold
- Companies
- 0
- With open-market trades
Trades
Every Form 4 that lists Braunstein Scott as a reporting owner, including filings made jointly with others, grouped by company. Each row adds up one type of transaction in one filing. Only open-market purchases (P) and sales (S) are shown by default.
MRNS Marinus Pharmaceuticals, Inc.
CHAIRMAN AND CEO4 trades
| Filed (ET) | Trade date | Filing delay | Insider | Transaction | Shares | Avg price | Value | Holding change | Flags |
|---|---|---|---|---|---|---|---|---|---|
| Feb 11, 2025 (view filing) | Aug 14, 2024 | 181 daysLate | Braunstein ScottCHAIRMAN AND CEO | PPurchase | +5.93K | $1.10 | +$6.53K | +2.0%304.6K after | |
| Aug 7, 2024 (view filing) | Aug 5 | 2 days | Braunstein ScottCHAIRMAN AND CEO | SSale | −12.1K | $1.13 | −$13.7K | −3.9%298.7K after | |
| Feb 21, 2024 (view filing) | Feb 16 | 5 days | Braunstein ScottCHAIRMAN AND CEO | SSale | −11.8K | $9.94 | −$117.8K | −5.0%223.5K after | |
| Aug 8, 2023 (view filing) | Aug 7-8 | 1 day | Braunstein ScottCHAIRMAN AND CEO | SSale | −6.44K | $9.55 | −$61.5K | −3.9%160.8K after | 2 lots10b5-1 |